Evidence map›Paper›PMID 29557190›Full record

ArticleAssessment2019

Extending the Construct Network of Trait Disinhibition to the Neuroimaging Domain: Validation of a Bridging Scale for Use in the European IMAGEN Project.

Sarah J Brislin, Christopher J Patrick, Herta Flor, Frauke Nees, Angela Heinrich, Laura E Drislane, James R Yancey, Tobias Banaschewski, Arun L W Bokde, Uli Bromberg and 24 more

Abstract readValidation Study
In one paragraph

Article in Assessment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Blunted Reward Sensitivity and Trait Disinhibition Interact to Predict Substance Use Problems.Clinical psychological science : a journal of the Association for Psychological Science · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Sarah J Brislin1 Florida State University, Tallahassee, FL, USA.
Christopher J Patrick1 Florida State University, Tallahassee, FL, USA.
Herta Flor2 Heidelberg University, Mannheim, Germany.
Frauke Nees2 Heidelberg University, Mannheim, Germany.
Angela Heinrich2 Heidelberg University, Mannheim, Germany.
Laura E Drislane4 University of Michigan, Ann Arbor, MI, USA.
James R Yancey1 Florida State University, Tallahassee, FL, USA.
Tobias Banaschewski2 Heidelberg University, Mannheim, Germany.
Arun L W Bokde5 The University of Dublin, Dublin, Ireland.
Uli Bromberg6 University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Christian Büchel6 University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Erin Burke Quinlan7 King's College London, London, England, UK.
Sylvane Desrivières7 King's College London, London, England, UK.
Vincent Frouin8 Université Paris-Saclay, Gif-sur-Yvette, France.
Hugh Garavan9 University of Vermont, Burlington, VT, USA.
Penny Gowland10 University of Nottingham, University Park, Nottingham, UK.
Andreas Heinz11 Charité-Universitätsmedizin Berlin, Berlin, Germany.
Bernd Ittermann12 Physikalisch-Technische Bundesanstalt, Braunschweig, Germany.
Jean-Luc Martinot13 University Paris Sud, Orsay, France.
Marie-Laure Paillère Martinot16 Maison de Solenn, Cochin Hospital, Paris, France.
Dimitri Papadopoulos Orfanos8 Université Paris-Saclay, Gif-sur-Yvette, France.ORCID 0000-0002-1242-8990
Luise Poustka2 Heidelberg University, Mannheim, Germany.
Juliane H Fröhner18 Technische Universität Dresden, Dresden, Germany.ORCID 0000-0002-8493-6396
Michael N Smolka18 Technische Universität Dresden, Dresden, Germany.
Henrik Walter11 Charité-Universitätsmedizin Berlin, Berlin, Germany.
Robert Whelan19 University College Dublin, Dublin, Ireland.
Patricia Conrod20 Université de Montréal, Quebec, Canada.
Argyris Stringaris21 National Institute of Mental Health, Bethesda, MD, USA.
Maren Struve2 Heidelberg University, Mannheim, Germany.
Betteke van Noort11 Charité-Universitätsmedizin Berlin, Berlin, Germany.
Yvonne Grimmer2 Heidelberg University, Mannheim, Germany.
Tahmine Fadai6 University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Gunter Schumann7 King's College London, London, England, UK.
Jens Foell1 Florida State University, Tallahassee, FL, USA.ORCID 0000-0002-2089-094X

Funding

Mood, Brain, and Development UnitZIAMH002957 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI STRINGARIS, ARGYRIOS · 2017 to 2022
$14.8M
Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
Axon, Testosterone and Mental Health during AdolescenceR01MH085772 · NIMH · BAYCREST CENTRE FOR GERIATRIC CARE · PI PAUS, TOMAS · 2010 to 2014
$1.5M
Medical Research Council MR/N000390/1Medical Research Council MR/N027558/1NIBIB NIH HHS U54 EB020403NIMH NIH HHS R01 MH085772
6 · The paper itself

Abstract

Trait disinhibition, a clinical-liability construct, has well-established correlates in the diagnostic, self-rating, task-behavioral, and brain potential response domains. Recently, studies have begun to test for neuroimaging correlates of this liability factor, but more work of this type using larger data sets is needed to clarify its brain bases. The current study details the development and validation of a scale measure of trait disinhibition composed of questionnaire items available in the IMAGEN project, a large-scale longitudinal study of factors contributing to substance abuse that includes clinical interview, self-report personality, task-behavioral, neuroimaging, and genomic measures. Using a construct-rating and psychometric refinement approach, a scale was developed that evidenced: (a) positive relations with interview-assessed psychopathology in the IMAGEN sample, both concurrently and prospectively and (b) positive associations with scale measures of disinhibition and reported psychopathology, and a robust negative correlation with P3 brain response, in a separate adult sample ( M

Indexed as

Inhibition, PsychologicalAdolescentBiomarkersBrainEuropeFemaleHumansLongitudinal StudiesMaleMental DisordersNeuroimagingPersonality DisordersPsychiatric Status Rating ScalesPsychometricsPsychopathologySubstance-Related DisordersBiomarkersexternalizing psychopathologyIMAGENliabilityneuroimagingtrait disinhibition

Identifiers

PMID29557190
PMCPMC11973889

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.